Financials BioNote, Inc.

Equities

A377740

KR7377740006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 03:30:00 22/05/2024 am IST 5-day change 1st Jan Change
4,240 KRW 0.00% Intraday chart for BioNote, Inc. +0.83% -0.12%

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 8,74,096 4,33,228
Enterprise Value (EV) 1 1,53,997 37,988
P/E ratio 2.63 x -21.1 x
Yield 5.71% 4.71%
Capitalization / Revenue 1.82 x 4.81 x
EV / Revenue 0.32 x 0.42 x
EV / EBITDA 0.51 x -0.98 x
EV / FCF 1.18 x -2.03 x
FCF Yield 84.4% -49.2%
Price to Book 0.55 x 0.28 x
Nbr of stocks (in thousands) 1,01,876 1,02,056
Reference price 2 8,580 4,245
Announcement Date 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales 1 4,79,657 90,081
EBITDA 1 3,01,861 -38,962
EBIT 1 2,95,410 -47,168
Operating Margin 61.59% -52.36%
Earnings before Tax (EBT) 1 4,14,778 -1,09,491
Net income 1 3,07,798 -20,497
Net margin 64.17% -22.75%
EPS 2 3,264 -201.0
Free Cash Flow 1 1,29,964 -18,697
FCF margin 27.1% -20.76%
FCF Conversion (EBITDA) 43.05% -
FCF Conversion (Net income) 42.22% -
Dividend per Share 2 490.0 200.0
Announcement Date 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - -
Net Cash position 1 7,20,100 3,95,240
Leverage (Debt/EBITDA) - -
Free Cash Flow 1 1,29,964 -18,697
ROE (net income / shareholders' equity) 21.4% -1.3%
ROA (Net income/ Total Assets) 11.4% -1.76%
Assets 1 27,05,605 11,64,575
Book Value Per Share 2 15,707 15,252
Cash Flow per Share 2 6,685 1,444
Capex 1 42,266 3,963
Capex / Sales 8.81% 4.4%
Announcement Date 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A377740 Stock
  4. Financials BioNote, Inc.